Biologic Options in Pediatric Asthma

The panel discusses the biologic drugs approved for use in children with asthma, including omalizumab, dupilumab, mepolizumab, and the recently approved benralizumab. They share their preferences among these options for improving lung function in pediatric patients.

Related Content:

Allergies, Asthma Exacerbations and Uncontrolled Asthma ManagementAsthmaPeer Exchange

Allergies and Asthma During the School Year, with S. Christy Sadeameli, MD, and Juanita Mora, MD

Back-to-School Asthma and Lung Health with Juanita Mora, MD and S. Christy Sadreameli, MD

Dupilumab Reduces Exacerbations Among Children with Severe Asthma Up to 2 Years